EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

Technologies Proposed capabilities Established science

The technology areas behind one traceable path, from botanical source to qualified ingredient

Each page gives the science, its limits, the planned in-house and partner scope, and what EUTECNIQ does not claim.

14technology pages
187figures and diagrams
97interactive tools
356evidence labels
382registered claims

Status. EUTECNIQ has no laboratory, equipment or data of its own yet. Every capability here is a proposal; the science is published work by others.

Technology map

Six stages, each with its technologies: select a stage to zoom, a page to open it

Technology pages grouped by the stage of ingredient development they serveSite structure
Built from the site navigation; tooltips give each page's figure and tool counts.
Bar on each card: evidence labels on that pageVerified dataPeer-reviewedRegulation or guidanceThird-party estimateProposal, partner or riskSimulation or schematic
Formulate and deliver

Advanced delivery

Carriers matched to the molecule's measured limits.

7 figures2 interactive
Formulate and deliver

Emulsions & colloids

Droplet size, stability and breakdown mechanisms.

13 figures7 interactive
Measure and validate

Analytical characterization

Identity, purity, potency and contaminants against specifications.

24 figures4 interactive
Make and scale

Process engineering

Balances, scale-up rules and process safety.

21 figures15 interactive
Model and translate

Translational research

Exposure, interactions and pharmacokinetics, up to drug rules.

7 figures3 interactive
Research activity

Published research behind every technology area grew from 2015 to 2025, fastest for machine learning and non-targeted analysis

MEDLINE records per year for each technology's research field, 2015 and 2025Europe PMC counts
MEDLINE records per year for the research field behind each technology page, 2015 and 2025, on a log scale, sorted by growth. Each row shows the 2015 and 2025 counts; the numbers are in the data table.1101001,00010,000MEDLINE records per year (log scale; a count of 0 is drawn at 1); hollow = 2015, solid = 2025ChangeMachine learning for natural productsMachine learning for natural products: 18 records in 2015Machine learning for natural products: 298 records in 2025×16.6Non-targeted analysis of plantsNon-targeted analysis of plants: 24 records in 2015Non-targeted analysis of plants: 358 records in 2025×14.9Food-grade nanoemulsionsFood-grade nanoemulsions: 34 records in 2015Food-grade nanoemulsions: 360 records in 2025×10.6Bioavailability of phytochemicalsBioavailability of phytochemicals: 279 records in 2015Bioavailability of phytochemicals: 1,563 records in 2025×5.6Delivery systems for phytochemicalsDelivery systems for phytochemicals: 45 records in 2015Delivery systems for phytochemicals: 235 records in 2025×5.2Scale-up of botanical processesScale-up of botanical processes: 43 records in 2015Scale-up of botanical processes: 201 records in 2025×4.7Spray and freeze drying of extractsSpray and freeze drying of extracts: 54 records in 2015Spray and freeze drying of extracts: 216 records in 2025×4.0Standardization of botanical extractsStandardization of botanical extracts: 55 records in 2015Standardization of botanical extracts: 208 records in 2025×3.8Process modeling of plant extractionProcess modeling of plant extraction: 7 records in 2015Process modeling of plant extraction: 24 records in 2025×3.4Advanced extraction of plantsAdvanced extraction of plants: 74 records in 2015Advanced extraction of plants: 232 records in 2025×3.1Natural-product dereplication and structure elucidationNatural-product dereplication and structure elucidation: 72 records in 2015Natural-product dereplication and structure elucidation: 221 records in 2025×3.1Randomized trials of botanicalsRandomized trials of botanicals: 38 records in 2015Randomized trials of botanicals: 111 records in 2025×2.9Chromatography and mass spectrometry of botanicalsChromatography and mass spectrometry of botanicals: 709 records in 2015Chromatography and mass spectrometry of botanicals: 2,014 records in 2025×2.8Validated methods for botanicalsValidated methods for botanicals: 22 records in 2015Validated methods for botanicals: 29 records in 2025×1.3
Source: Europe PMC REST API, query TITLE_ABS:(terms) AND SRC:MED AND PUB_YEAR:year, run October 24, 2026; search terms in the data table. A count is the number of matching MEDLINE records, not of studies on each page's exact subject.
The same fields year by year, 2000–2025, each row scaled to its own peak; select a year to sortEurope PMC counts
Same query and date as above. Narrow screens show every second or fifth year. Counts for the latest years can still rise as indexing continues.
Data table and search terms
MEDLINE records per year in Europe PMC whose title or abstract matches the search terms
Topic (page)2000200520102015202020242025CAGR 2015–2025Search terms in title or abstract
Natural-product dereplication and structure elucidation1031247213015122111.9%(("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") OR "natural product" OR "natural products") AND (dereplication OR "structure elucidation" OR "molecular networking")
Non-targeted analysis of plants0272410923235831.0%("non-targeted" OR nontargeted OR untargeted) AND (metabolomics OR "high-resolution mass spectrometry" OR HRMS) AND (plant OR plants OR botanical OR herbal)
Advanced extraction of plants812457414821323212.1%("supercritical carbon dioxide" OR "supercritical CO2" OR "pressurized liquid extraction" OR "ultrasound-assisted extraction" OR "microwave-assisted extraction") AND (plant OR plants OR herb OR herbs OR botanical OR leaves OR seeds OR roots)
Standardization of botanical extracts101944558810320814.2%("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") AND (standardization OR standardisation OR "marker compound" OR "marker compounds")
Delivery systems for phytochemicals75174511819223518.0%(nanoemulsion OR liposome OR liposomes OR phytosome OR phytosomes OR "self-emulsifying") AND (("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") OR curcumin OR polyphenol OR polyphenols)
Bioavailability of phytochemicals46621762796249461,56318.8%bioavailability AND (("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") OR polyphenol OR polyphenols OR curcumin OR flavonoid OR flavonoids)
Food-grade nanoemulsions0083415530236026.6%(nanoemulsion OR nanoemulsions OR "Pickering emulsion" OR "Ostwald ripening") AND (food OR nutraceutical OR nutraceuticals OR "essential oil" OR "essential oils")
Spray and freeze drying of extracts1112265413617721614.9%("spray drying" OR "spray-drying" OR "spray dried" OR "freeze drying" OR "freeze-drying" OR lyophilization) AND (extract OR extracts OR polyphenol OR polyphenols OR anthocyanin OR anthocyanins)
Chromatography and mass spectrometry of botanicals691543157091,1821,5882,01411.0%("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") AND ("liquid chromatography" OR HPLC OR UHPLC OR "mass spectrometry")
Validated methods for botanicals054222023292.8%("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") AND ("method validation" OR "validated method" OR "ICH guidelines" OR "ICH Q2")
Process modeling of plant extraction02479192413.1%("mathematical model" OR "mass transfer" OR "techno-economic" OR "process simulation") AND extraction AND (plant OR plants OR botanical OR seeds OR leaves)
Scale-up of botanical processes101921438814620116.7%("scale-up" OR "pilot scale" OR "pilot-scale" OR "industrial scale") AND (("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") OR "dietary supplement" OR extraction)
Machine learning for natural products022185516829832.4%("machine learning" OR "deep learning" OR "neural network") AND (("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants") OR "natural product" OR "natural products")
Randomized trials of botanicals192038888711111.3%("randomized controlled trial" OR "randomised controlled trial" OR "randomized clinical trial") AND ("plant extract" OR "plant extracts" OR botanical OR herbal OR phytochemical OR phytochemicals OR "medicinal plant" OR "medicinal plants")
Evidence

Most technology pages rest on published science and labeled simulations; the plans are marked as proposals

Share of each page's evidence labels by kind; select a column to sortCounted at build time
Every evidence label printed on each page, counted when the site is built. Label key: insights library.
Data table
Evidence labels on each technology page, by family, counted at build time
PageLabelsVerified dataPeer-reviewedRegulation or guidanceThird-party estimateProposal, partner or riskSimulation or schematic
Discovery & characterization3414 (41%)9 (26%)3 (9%)0 (0%)6 (18%)2 (6%)
Targeted and non-targeted analysis248 (33%)3 (12%)0 (0%)0 (0%)2 (8%)11 (46%)
Extraction & purification277 (26%)2 (7%)3 (11%)0 (0%)5 (19%)10 (37%)
Purification & standardization281 (4%)7 (25%)1 (4%)0 (0%)6 (21%)13 (46%)
Advanced delivery182 (11%)2 (11%)5 (28%)0 (0%)3 (17%)6 (33%)
Bioavailability by design140 (0%)6 (43%)0 (0%)0 (0%)2 (14%)6 (43%)
Emulsions & colloids210 (0%)7 (33%)0 (0%)0 (0%)4 (19%)10 (48%)
Drying & particle engineering250 (0%)6 (24%)2 (8%)0 (0%)5 (20%)12 (48%)
Analytical characterization311 (3%)0 (0%)2 (6%)0 (0%)8 (26%)20 (65%)
Analytical method development222 (9%)0 (0%)4 (18%)0 (0%)5 (23%)11 (50%)
Process engineering535 (9%)2 (4%)2 (4%)0 (0%)13 (25%)31 (58%)
Scale-up and tech transfer192 (11%)5 (26%)2 (11%)0 (0%)3 (16%)7 (37%)
Computational science & AI245 (21%)3 (12%)0 (0%)0 (0%)10 (42%)6 (25%)
Translational research161 (6%)3 (19%)4 (25%)0 (0%)5 (31%)3 (19%)
Integrated pathway

The areas connect in one sequence, and each stage ends in a decision

Eight stages, each ending in a gate that can advance, return or stop a candidateProposed sequence
Eight proposed stages from botanical source to a specified ingredient, licensable process or a documented stop, with a decision gate after each stage that can send a candidate back or stop itBotanicalsourceSupplier, origin,plant part,voucherIdentityOrthogonal testsagainstreferencesMolecularcharacterizationFingerprints,markers,contaminants,variabilitySafety andinteractionsExposure,interaction andtoxicologyquestionsDeliveryengineeringCarriers chosenfrom themolecule's limitsProcessscale-upExtraction, dryingand transfer toscaleRegulatorystrategyPathway for theproduct categoryand marketIngredient,technologyor IPOr a stop, withreasonsEach stage ends in a decision gate: go, send back, or stopA candidate can be sent back or stopped at any gate; the platform page lists the criteria and the document each stage producesEight proposed stages from botanical source to a specified ingredient, licensable process or a documented stop, with a decision gate after each stage that can send a candidate back or stop itBotanical sourceSupplier, origin, plant part, voucherIdentityOrthogonal tests against referencesMolecular characterizationFingerprints, markers, contaminants, variabilitySafety and interactionsExposure, interaction and toxicology questionsDelivery engineeringCarriers chosen from the molecule's limitsProcess scale-upExtraction, drying and transfer to scaleRegulatory strategyPathway for the product category and marketIngredient, technology or IPOr a stop, with reasonsGate after each stage: go, send back, or stop
EUTECNIQ proposal; decision criteria and stage documents are on the platform page.
Text version of the eight stages, with links
  1. Botanical sourceSupplier, origin, plant part, voucher. Discovery
  2. IdentityOrthogonal identity tests against references. Analytical
  3. Molecular characterizationFingerprints, markers, contaminants, variability.
  4. Safety and interactionsExposure, interaction and toxicology questions. Translational
  5. Delivery engineeringCarriers chosen from the molecule's limits. Delivery
  6. Process scale-upExtraction, drying and transfer to scale. Process
  7. Regulatory strategyPathway for the product category and market. Regulatory
  8. Ingredient, technology or IPA specified ingredient, a licensable process, or a stop with reasons.
Eight pairs these pages never treat as the same thingTerminology
  • Laboratory feasibility≠Commercial demonstration
  • Extraction yield≠Purity or recovery
  • Nanoemulsion stability≠Demonstrated bioavailability
  • Bioaccessibility≠Systemic bioavailability
  • In vitro activity≠Clinical efficacy
  • Stability testing≠Validated shelf life
  • An educational model≠A measurement
  • A proposed capability≠An existing one
Terms as defined on the linked pages and in the Academy courses; the site's writing standard keeps each pair apart.
In house or partner

The laboratory core would be built first; specialist and regulated work would go to qualified partners

In-house capability by facility phase, and the work placed with partnersProposed split
Proposed split of work by area: in-house capabilities by facility phase, and work placed with qualified partners. No facility has been built and no partner agreement signed.Phase I · laboratory corePhase II · pilotPhase III · commercialQualified partnerDiscovery andcharacterizationMicroscopy, HPTLC, HPLC,LC-MS, ICP-MS,microbiologyDNA barcoding, NMR, accreditedconfirmatory testsExtraction and purificationLaboratory extractionPilot extraction,evaporation, solventrecoveryToll extraction at commercial scaleDelivery, emulsions,dryingLaboratory formulation anddryingPilot dryingHuman pharmacokinetic studiesand bioanalysisProcess scale-upLaboratory processPilot plantCommercialmanufacturingContract manufacturers untilPhase IIITranslational and safetyPlanned, phase not set: exposure and literature assessment, study design, dossierwritingToxicology studies (GLP whereappropriate), human studiesFacilities roadmap: Phase I is the laboratory core, Phase II adds pilot processing after its decision gate, Phase III adds commercial manufacturing.
EUTECNIQ proposal, consistent with the platform plan and the facilities roadmap as of October 2026.
Text version of the in-house and partner split
Proposed in-house capabilities by phase and partner work, by technology area
AreaPlanned in houseQualified external partner
Discovery and characterizationPhase I Microscopy, HPTLC, HPLC, LC-MS, ICP-MS, microbiologyPartner DNA barcoding, NMR, accredited confirmatory tests
Extraction and purificationPhase I Laboratory extraction; Phase II pilot extraction, evaporation and solvent recoveryPartner Toll extraction at commercial scale
Delivery, emulsions, dryingPhase I Laboratory formulation and drying; Phase II pilot dryingPartner Human pharmacokinetic studies and bioanalysis
Process scale-upPhase I Laboratory process; Phase II pilot plant; Phase III commercial manufacturingPartner Contract manufacturers until Phase III
Translational and safetyPlanned Exposure and literature assessment, study design, dossier writingPartner Toxicology studies (GLP where appropriate), human studies
Explanation, details and sources

"In house" means a capability planned for a proposed facility phase; "partner" means work placed with a qualified outside organization under a written agreement. No facility has been built and no partner agreement signed.

Have a botanical or a technical problem to discuss?

Describe the material, the target product and the question. EUTECNIQ is in formation and would respond with a proposed plan and the evidence each step would produce.

Discuss a development program